Von Hippel-lindau Disease-associated Renal Cell Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2021-08-13
FDA Approved: WELIREG — Original Application (Merck Sharp & Dohme LLC)
The FDA granted original approval for Welireg (belzutifan) from Merck Sharp & Dohme LLC for von Hippel-Lindau disease–associated tumors incl…